Trial Profile

PSMA-PET Registry for Recurrent Prostate Cancer

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 20 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Piflufolastat F18 (Primary)
Indications Prostate cancer
Focus Diagnostic use
Acronyms PREP

Most Recent Events

16 Mar 2023 Planned End Date changed from 1 Dec 2023 to 1 Dec 2025.
16 Mar 2023 Planned primary completion date changed from 1 Dec 2022 to 1 Mar 2024.
01 Sep 2022 Results assessing performance of 18F-DCFPyL PET/CT or PET/MRI with bone scan and CT with or without multiparametric MRI using data from two clinical studies: NCT03535831 and NCT03718260 published in the Radiology

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com